Clinical Drug Experience Knowledgebase

Carcinoma, Non-Small-Cell Lung (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Cytomegalovirus Infections (Phase 1)

Graft vs Host Disease (Phase 2)

Hodgkin Disease (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Nasopharyngeal Carcinoma (Phase 1)

Neuralgia (Phase 1)

Osteoarthritis (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 3)

Spondylarthritis (Phase 3)

Ulcer (Phase 2)

Urinary Bladder Neoplasms (Phase 3)

Urticaria (Phase 3)